Table 3.
New Bone (%) | TCP (%) | Fibrous Tissue (%) | |
---|---|---|---|
Control | 14.19 (13.00;17.25) | 10.29 (9.53;11.43) | 16.44 (8.21;18.54) |
Zoledronate | 16.84 (12.34;19.23) | 12.11 (8.39;14.23) | 14.70 (5.55;22.13) |
p-value | 0.58 | 0.80 | 0.88 |
Data are presented as median for each treatment group with interquartile range in parenthesis.